CureVac N.V. (CVAC) Financials

CVAC Assets vs Liabilities

DateAssetsLiabilities
Nov. 24, 2025 ? ?
Sept. 30, 2025 1.3 billion 313.8 million
June 30, 2025 812.0 million 120.8 million
March 31, 2025 803.0 million 103.4 million

CVAC Free Cash Flow and Stock based compensation

Graph available only for paid members. Upgrade to see it.
DateFree Cash FlowStock based compensation
Nov. 24, 2025 ? ?
Sept. 30, 2025 34.7 million 1.7 million
June 30, 2025 -51.4 million 1.8 million
March 31, 2025 -45.3 million 1.3 million

CVAC Net Income

No data available :(

CVAC Cash and Debt

Graph available only for paid members. Upgrade to see it.
DateCashDebtCapital Lease
Nov. 24, 2025 - - -
Sept. 30, 2025 - - 41.2 million
June 30, 2025 466.5 million 36.7 million 42.5 million
March 31, 2025 478.3 million 34.8 million 40.4 million

CVAC Shares Outstanding

Graph available only for paid members. Upgrade to see it.
DateShares Outstanding
Nov. 24, 2025 ?
Sept. 30, 2025 264.2 million
June 30, 2025 265.4 million
March 31, 2025 243.6 million

CVAC Expenses

Graph available only for paid members. Upgrade to see it.
DateCapexR&DG&AS&M
Nov. 24, 2025 - -57.6 million -19.2 million -1.8 million
Sept. 30, 2025 377876 58.7 million 29.8 million 1.8 million
June 30, 2025 1.8 million 41.1 million 26.7 million 1.5 million
March 31, 2025 552805 40.7 million 18.9 million 1.0 million

CVAC Cost of Revenue

Graph available only for paid members. Upgrade to see it.
DateRevenueCost of Revenue
Nov. 24, 2025 568.9 million -25.3 million
Sept. 30, 2025 579.6 million -25.7 million
June 30, 2025 1.5 million 2.6 million
March 31, 2025 966058 946585

CVAC

Price: $4.66

52 week price:
2.48
5.72

Earnings Per Share: 0.67 USD

P/E Ratio: 6.97

Exchange: NGM

Sector: Healthcare

Industry: Biotechnology

Country: Germany

Volume: 537100

Market Capitalization: 1.1 billion

Links: